Harmony Biosciences Holdings Inc. (HRMY): Price and Financial Metrics

Harmony Biosciences Holdings Inc. (HRMY): $29.19

0.59 (-1.98%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

A

Add HRMY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#23 of 363

in industry

HRMY Price/Volume Stats

Current price $29.19 52-week high $39.26
Prev. close $29.78 52-week low $18.61
Day low $29.12 Volume 364,000
Day high $30.07 Avg. volume 374,170
50-day MA $31.95 Dividend yield N/A
200-day MA $31.51 Market Cap 1.66B

HRMY Stock Price Chart Interactive Chart >


Harmony Biosciences Holdings Inc. (HRMY) Company Bio


Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded on July 25, 2017 and is headquartered in Plymouth Meeting, PA.


HRMY Latest News Stream


Event/Time News Detail
Loading, please wait...

HRMY Latest Social Stream


Loading social stream, please wait...

View Full HRMY Social Stream

Latest HRMY News From Around the Web

Below are the latest news stories about HARMONY BIOSCIENCES HOLDINGS INC that investors may wish to consider to help them evaluate HRMY as an investment opportunity.

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks.

Josh Enomoto on InvestorPlace | December 17, 2023

Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On

While all eyes may be on the usual suspects of market hype and influence, astute investors with a contrarian streak may want to consider Russell 2000 stocks.

Josh Enomoto on InvestorPlace | December 8, 2023

HRMY or GMAB: Which Is the Better Value Stock Right Now?

HRMY vs. GMAB: Which Stock Is the Better Value Option?

Yahoo | December 7, 2023

HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1

Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY) today announced positive topline results from its Phase 2 signal detection study evaluating the safety and efficacy of pitolisant in adult patients with myotonic dystrophy type 1 (DM1).

Yahoo | December 7, 2023

16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds

In this article, we will take a look at the 16 most undervalued small-cap stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds. Despite strong signs that the central bank would be ready to hit brakes on its […]

Yahoo | December 5, 2023

Read More 'HRMY' Stories Here

HRMY Price Returns

1-mo -9.71%
3-mo -7.80%
6-mo 45.01%
1-year -11.46%
3-year 7.67%
5-year N/A
YTD -9.63%
2023 -41.38%
2022 29.22%
2021 17.95%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!